In this special edition of the View, Kim A. Eagle, MD, MACC, talks with Philippe Gabriel Steg, MD, FACC, and Payal Kohli, MD, FACC, about four of the major trials that were presented on Day 2 of the ESC Congress in Amsterdam on Saturday, Aug. 26.

The trials include ECLS-SHOCK (0:44) that investigates extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock, CLEAR-Outcomes (03:34), looking at bempedoic acid and cardiovascular outcomes in statin-intolerant patients, STOPDAPT 3 (06:33) exploring the benefit of the prasugrel monotherapy without aspirin as compared with the 1-month dual therapy with aspirin and prasugrel in terms of reducing bleeding events after PCI using cobalt-chromium everolimus-eluting stents in patients with high bleeding risk or acute coronary syndrome patients, and FIRE (09:47) studying functional vs. culprit-only revascularization in elderly patients with myocardial infarction and multivessel disease.

The ACC is providing coverage of the latest science being presented at ESC Congress 2023 in Amsterdam. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ESCCongress.

Clinical Topics: Anticoagulation Management, Cardiac Surgery, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Vascular Medicine, Atherosclerotic Disease (CAD/PAD), Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Coronary Artery Disease, Interventions and Imaging, Interventions and Vascular Medicine, Angiography, Nuclear Imaging, Acute Coronary Syndromes, Arrhythmias and Clinical EP, Cardio-Oncology, Cardiovascular Care Team, Congenital Heart Disease and Pediatric Cardiology, COVID-19 Hub, Geriatric Cardiology, Pericardial Disease, Pulmonary Hypertension and Venous Thromboembolism, Sports and Exercise Cardiology, Stable Ischemic Heart Disease, Valvular Heart Disease

Keywords: ESC Congress, ESC23, EaglesEyeView, ACC International, Shock, Cardiogenic, Respiratory Physiological Phenomena, Atherosclerosis, Cholesterol, LDL, Coronary Artery Disease, C-Reactive Protein, Dyslipidemias, Ezetimibe, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocardial Infarction, Myocardial Revascularization, PCSK9 protein, human, Peripheral Arterial Disease, Primary Prevention, Secondary Prevention, Stroke, Aspirin, Fibrinolytic Agents, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Anticoagulants, Fractional Flow Reserve, Myocardial, Coronary Angiography

< Back to Listings